RSS
Kidney Health Alliance
EMA accepts marketing authorisation application for avacopan
The European Medicines Agency (EMA) has accepted the conditional marketing authorisation application for avacopan in the treatment of patients with anti-neutrophil cytoplasmic antibody associated vasculitis. Read more